Advertisement

Topics

The Debiopharm Group Company Profile

07:06 EDT 26th September 2017 | BioPortfolio

Debiopharm Group(TM) (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses, develops and/or co-develops promising biological and small molecule drug candidates having reached clinical development phases I, II or III. Debiopharm is also prepared to consider earlier stage candidates. It develops its products for global registration and maximum commercial potential. The products are out-licensed to pharmaceutical partners for sales and marketing. Besides drug development, Debiopharm Group(TM) has recently embarked in the field of companion diagnostics with a view to progressing in the area of personalised medicine.


News Articles [658 Associated News Articles listed on BioPortfolio]

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Tuesday, May 23rd 2017 at 8:01pm UTC Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with Immuno...

Debiopharm gets ADC candidate from ImmunoGen

ImmunoGen Inc. granted Debiopharm International SA all rights to its anti-CD37 antibody-drug conjugate IMGN529 (naratuximab emtansine) for B-cell malignancies. Debiopharm, which gains its first ADC pr...

Arbor Pharmaceuticals, LLC Announces FDA Approval for Triptodur (triptorelin)

Atlanta, GA and Lausanne, Switzerland – June 30, 2017 – Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, and Debiopharm International SA, part of Debiopharm Group™, a S...

Almac Discovery y Debiopharm International SA anuncian el desarrollo de un nuevo inhibidor Wee-1

Almac Discovery ( http://www.almacgroup.com/discovery), una compañía biofarmacéutica centrada en el descubrimiento e identificación de terapéuticos innovadores para el tratamiento del cáncer, ...

Debiopharm gains rights to a novel Wee-1 inhibitor program

Almac Discovery has entered into a collaboration with Debiopharm International on the development of…

Debiopharm moves into antibody-drug conjugates acquiring Ph II assets

Debiopharm has acquired ImmunoGen’s IMGN529/DEBIO1562, a clinical-stage anti-CD37 ADC for the treatment…

ImmunoGen sells off ADC to Debiopharm

Debiopharm moves into antibody-drug conjugates as it buys ImmunoGen’s IMGN529 in a $55 million deal.

FDA Approves Triptodur for Treatment of Patients 2 Years and Older with Central Precocious Puberty

ATLANTA and LAUSANNE, Switzerland, June 30, 2017 /PRNewswire/ — Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, and Debiopharm International SA, part of Debiopharm Gro...

PubMed Articles [2648 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Protective effects of Tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar Albino rats.

The aim of this study was to investigate the antioxidant effects of tempol on ovarian ischemia-reperfusion injury in rats. Forty female Wistar albino rats were randomly divided into five groups: Group...

Effects of leptin on femoral fracture in rats.

In this study, our objective was to evaluate effects of leptin on fracture healing in rats. Seventy two male Sprague-Dawley (SD) rats were randomized into 3 groups. Standardized femoral fractures were...

Keeping up appearances: Strategic information exchange by disidentified group members.

Information exchange is a crucial process in groups, but to date, no one has systematically examined how a group member's relationship with a group can undermine this process. The current research exa...

Clinical Trials [3132 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Companies [1566 Associated Companies listed on BioPortfolio]

The Debiopharm Group

Debiopharm Group(TM) (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-l...

Debiopharm Galenic Unit

Debiopharm, Debiovision, Debioinnovation, Debio R.P. and Debioclinic form an established group of five complementary and synergistic companies. Together, they provide drug development expertise and kn...

Debiopharm Group

Debio 025 is an oligopeptide that has some chemical features in common with cyclosporine A, but is devoid of its immunosuppressive pharmacological effects. It has a very potent inhibitory effect o...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "The Debiopharm Group" on BioPortfolio

We have published hundreds of The Debiopharm Group news stories on BioPortfolio along with dozens of The Debiopharm Group Clinical Trials and PubMed Articles about The Debiopharm Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Debiopharm Group Companies in our database. You can also find out about relevant The Debiopharm Group Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record